Humankind’s 200 or so RNA-binding proteins have proved once again to be a plentiful hunting ground for genes linked to neurodegeneration—particularly when they include prion-like sequences. In the March 3 Nature online, researchers led by Paul Taylor of St. Jude Children’s Research Hospital in Memphis, Tennessee, report that mutations in two heterogeneous nuclear ribonucleoproteins—hnRNPA2B1 and hnRNPA1—cause amyotrophic lateral sclerosis (ALS) and multisystem proteinopathy (MSP), also known as inclusion body myopathy-Paget’s disease of bone. These hnRNPs join other RNA-binding proteins that have been linked to neurodegenerative disease, including TDP-43, FUS, TAF15, and EWS (see ARF related news story on Couthouis et al., 2011). They all have prion-like domains where disease mutations occur. Taylor and colleagues found that the prion-like regions in the hnRNPs contain "steric zipper" motifs that encourage protein-protein binding. The disease-causing mutations enhanced protein zipping, promoting pathological aggregation. Other RNA-binding proteins with prion-like domains may also contribute to disease in a similar fashion, the authors propose. Study collaborator James Shorter of the University of Pennsylvania has identified 20 such genes that may be linked to disease.

“These findings further support the important role of RNA binding proteins in ALS, frontotemporal lobar degeneration, and related multisystem proteinopathies,” wrote Christian Haass of Ludwig Maximilians University in Munich, Germany, in an e-mail to Alzforum (see full comment below). Haass, who was not involved in the current work, recently discovered that another hnRNP, A3, occurs in protein deposits in brain samples from people who have ALS or frontotemporal lobar degeneration due to an expansion in the C9ORF72 gene (see ARF related news story on Mori et al., 2013).

New Mutations
Researchers in Taylor’s lab study multisystem proteinopathy, a complex and variable syndrome. Afflicted family members exhibit degeneration in bone, muscle, neurons, or a combination of any of these three. It is unknown why these tissue types are susceptible, Taylor said. The neurodegeneration can take the form of ALS or frontotemporal dementia (Nalbandian et al., 2011; see ARF related news story on Johnson et al., 2010).

Taylor’s group previously discovered that mutations in valosin-containing protein (VCP) cause MSP (Watts et al., 2004). VCP is a kind of chaperone called a segregase, which acts to disassemble many kinds of protein complexes. Among its targets are stress granules—temporary mRNA-laden aggregates that shut down protein translation to help cells conserve energy during stressful events. Suspected pathological stress granules have been associated with TDP-43 (see ARF related news story), FUS (see ARF related news story on Dormann et al., 2010), and tau in Alzheimer’s disease (see ARF related news story and ARF news story on Vanderweyde et al., 2012).

Taylor initially believed that familial multisystem proteinopathy was solely due to VCP mutations, but over time he identified more than a dozen MSP families that possessed normal VCP. Co-first author Hong Joo Kim found the hnRNP mutations when she used exome sequencing to analyze DNA from two of those families. The hnRNPA2B1 and hnRNPA1genes are closely related, and in each case the mutation replaced a conserved aspartate with valine. The researchers, including co-first authors Nam Chul Kim, Yong-Dong Wan, and Jennifer Moore, were intrigued because of the similarities between the hnRNPs and TDP-43. “They are paralogous proteins,” Taylor said. They also work together. TDP-43 binds both hnRNPs, and all three regulate mRNA splicing (Buratti et al., 2005). Further, the researchers thought it important that the aspartate-to-valine substitution occurred in the same carboxyl-terminal, glycine-rich, prion-like region where many TDP-43 ALS mutations turn up.

Taylor contacted collaborators to check if the genetic association held up in other families. Christopher Shaw of King’s College London, U.K., and Rosa Rademakers of the Mayo Clinic in Jacksonville, Florida, each found a person with ALS who harbored an hnRNPA1 mutation. Shaw found a substitution at the same aspartate that Taylor’s group identified, but in this case the mutation was to an asparagine. Rademakers identified a nearby asparagine-to-serine mutation. With four instances of hnRNP variants found in fewer than 600 families, Taylor concluded that, while the mutations are uncommon, they are not extremely rare.

Broken Zippers
To understand how the mutations affected the hnRNP proteins, Taylor collaborated with Shorter's group, including co-first authors Emily Scarborough and Zamia Diaz. The researchers purified recombinant versions of the two hnRNPs and found they formed fibrils in vitro. The disease-linked mutants fibrillized faster. Based on computational analysis of the amino acid sequence, the researchers ascribe this aggregation to the steric zipper motif. “The mutations really intensify the strength of that binding,” Shorter said. The resulting complexes, then, act like stuck zippers.

Kim found that in HeLa cervical cancer cultures the mutations affected stress granule assembly, which depends on prion-like protein domains (Kato et al., 2012). Though the wild-type proteins were normally nuclear, they relocated to cytoplasmic stress granules when Kim treated the cells with arsenite. In contrast, the mutant hnRNPs appeared in stress granules even before the treatment. After it, additional mutant hnRNPs joined stress granules, and did so more quickly than the wild-type proteins.

The results led Taylor to propose that MSP is a disease of pathological stress granules held together by stuck zippers. Stress granules are supposed to dissolve when the cells' situation improves. “You normally have an equilibrium,” said Ben Wolozin of Boston University, who was not involved with the Nature study. “If you shift that towards aggregation, then the system begins to develop stress granules that are too stable and too big.” This disequilibrium could underlie the formation of many neurodegeneration-linked aggregates, Wolozin has posited (Wolozin, 2012).

What turns a short-lived stress granule into a disease-causing aggregate? An additional stressor could initiate the transition, Haass proposed, and hnRNP mutations could fit the bill. In that way, he suggested, mutant hnRNPs might seed or even spread aggregation because their zippers are too tight. Alternatively, in people with VCP mutations, the chaperone is unable to unzip the complexes. In both cases, aggregates could cause disease by sequestering RNAs and their binding proteins, Taylor suggested.

Prion Pathology
The discovery of hnRNPA2B1 and A1 mutations in ALS and MSP fits nicely with a hypothesis that Shorter, along with collaborator Aaron Gitler of Stanford University in Palo Alto, California, has been pursuing. They propose that a broad set of RNA-binding proteins with prion-like domains contribute to neurodegeneration by converting normally folded protein into toxic conformations. Based on computational analysis, the researchers put together a list of proteins with such features that they are checking for prion-like activity and participation in neurodegeneration (King et al., 2012). In fact, hnRNPA2B1 and hnRNPA1 were on Shorter’s list of top 10 gene candidates before he heard from Taylor.

The possibility of prion-like spread could explain the known pathology of ALS and MSP, which tends to start in one part of the body and move to neighboring tissues, noted Amelie Gubitz of the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland, in an e-mail to Alzforum (see full comment below; see also Ravits and La Spada, 2009). This kind of cell-to-cell, templated transmission has already been reported for tau (see ARF related news story on Luk et al., 2012), Aβ (see ARF related news story), and the ALS protein SOD1 (see ARF related news story). While Taylor and colleagues have yet to directly address prion-like transmission, they did show that each mutant protein could seed fibril formation with their wild-type counterparts.

The study authors expect that additional RNA-binding proteins with prion-like segments will join TDP-43 and the hnRNPs as factors in neurodegeneration. Taylor has DNA from other MSP families to sequence, and he anticipates discovering mutations in genes that either bind RNAs, as do the hnRNPs, or disassemble RNA-protein complexes, as does VCP. Shorter and Gitler are exploring the other genes on their list by using yeast as a model system and by staining pathological tissue samples for protein aggregates.—Amber Dance.

Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, Kanagaraj AP, Carter R, Boylan KB, Wojtas AM, Rademakers R, Pinkus JL, Greenberg SA, Trojanowski JQ, Traynor BJ, Smith BN, Topp S, Gkazi AS, Miller J, Shaw CE, Kottlors M, Kirschner J, Pestronk A, Li YR, Ford AF, Gitler AD, Benatar M, King OD, Kimonis VE, Ross ED, Weihl CC, Shorter J, Taylor JP. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 3 Mar 2013. Abstract


Make a Comment

To make a comment you must login or register.

Comments on News and Primary Papers

  1. What an interesting and fantastic story! The hnRNP A2B1 gene was the top candidate in our recent isolation of proteins binding to the C9ORF72 hexanucleotide repeats (Mori et al., 2013). Moreover, we also saw for another hnRNP (hnRNP A3) a cytoplasmic redistribution and nuclear clearance. That protein also contains the domain where the mutations were found in hnRNPA2B1 and hnRNPA1. Furthermore, we previously proposed that stress granules may be "precursors" of the final deposits (Dormann and Haass, 2011; Dormann et al., 2010). To convert reversible stress granules into insoluble deposits, we proposed additional stress was necessary, and one may speculate now that such stress may come from mutant hnRNPs, which could serve as seeds for irreversible aggregation and maybe even spreading. However, we could not confirm that mutations in TDP-43 favor stress granule formation (Bentmann et al., 2012). Nevertheless, the identification of disease-causing mutations in hnRNPA2B1 and hnRNPA1 unequivocally proves that at least these two hnRNPs are directly involved in the disease, and, based on the strong sequence homology, I would also predict that mutations will be found in hnRNPA3. Finally, these findings further support the important role of RNA binding proteins in ALS, FTLD, and related multisystem proteinopathies.


    . hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 2013 Mar;125(3):413-23. PubMed.

    . TDP-43 and FUS: a nuclear affair. Trends Neurosci. 2011 Jun 21; PubMed.

    . ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010 Aug 18;29(16):2841-57. PubMed.

    . Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J Biol Chem. 2012 Jun 29;287(27):23079-94. PubMed.

  2. This study by Paul Taylor and Jim Shorter is highly interesting to my laboratory. We study how RNA-binding proteins (RBPs) affect RNA processing in the context of neurobiology and neurodegenerative diseases. This study shows that prion-like domains or "low-complexity sequences" (Kato et al., 2012) seem to play a key role in RNA granule assembly, in particular, during cellular stress. The observation that these glycine-rich domains are found within these heterogeneous nuclear ribonucleoproteins (hnRNPs) A2/B1 and A1 (as well as TDP-43 and FUS/TLS), and that defects in these regions result in aberrant/enhanced polymerization and recruitment into stress granules, underscores the importance of understanding the normal function of these RBPs during stress. HnRNP proteins are involved with controlling alternative splicing, RNA stability, and polyadenylation of endogenous substrates in a variety of cell types.

    Paul and Jim's fascinating study leads to several key questions. First, why are these proteins implicated in RNA granule assembly/formation? Second, does a disruption in RNA granule recruitment cause a disruption of RNA metabolism? Third, we showed that more than half of alternative exons regulated by hnRNP proteins are affected by more than two hnRNPs (Huelga et al., 2012), implying synergistic actions by these hnRNPs on mRNA targets. Are other hnRNPs also implicated in neurological disease, given the large degree of crosstalk among hnRNP proteins? Last, is there cell-type specific vulnerability—and are RNA substrates that are affected during stress granule formation different in the brain, muscle, and bone?

    View all comments by Gene W. Yeo
  3. This collaborative research study provides new clues into how mutations in RNA-binding proteins may lead to degenerative disease. In the search for a causative gene mutation in a family with inherited multisystem proteinopathy (MSP) that was negative for VCP mutations, the authors identified a pathogenic mutation in the gene that codes for the heterogeneous nuclear ribonucleoprotein hnRNPA2B1. Intriguingly, genetic analysis of a second VCP-negative MSP family and an ALS family identified similar mutations in hnRNPA1. Given that the protein products of these genes function as “housekeepers” with critical roles in mRNA processing, these gene discoveries add to the growing body of evidence that dysfunctional mRNA metabolism plays a major role in degenerative disease.

    Muscle biopsies of affected individuals of the MSP families revealed abnormal sarcoplasmic inclusions of hnRNPA2B1, hnRNPA1, and TDP-43 in a subset of muscle fibers. This type of pathology is not completely unexpected, given that cytoplasmic inclusions of nuclear RNA binding proteins—especially TDP-43—in affected cells are a hallmark of ALS and related disorders. Kudos to the researchers who left no stone unturned and investigated the molecular triggers that drive this pathology by using computational algorithms. This bioinformatics-based analysis revealed that the disease-linked mutations fall into predicted prion-like domains of hnRNPA2B1 and A1, and strengthen a steric zipper motif, which accelerates self-seeding fibrillization. The implications of such increased propensity to form fibrils could be multifold. First, as shown in cell culture, it appears to increase the recruitment of hnRNPA2B1 and A1 into cytoplasmic stress granules, with likely negative consequences on RNA metabolism. Second, while not directly addressed in this study, it may also explain the regional cell-to-cell spreading pathology that is so typical for ALS and MSP. Whether this self-seeding fibrillization can be arrested is an important question for future research.


News Citations

  1. DC: New ALS Genetics Hog the Limelight at Satellite Conference
  2. Second Study Sees Intron in FTLD Gene Translated
  3. Adding ALS to the Manifestations of VCP Mutations
  4. Honolulu: TDP-43 Gets a Place in the Sun
  5. Going Nuclear: First Function for FUS Mutants
  6. DC: What’s That New Stuff in and Around Nuclei of AD Cells?
  7. Paper Alert: Stress Granules Get Tangled Up in Tau
  8. Toxic Synuclein Corrupts Native in Wild-Type Mice
  9. Seeds of Destruction—Prion-like Transmission of Sporadic AD?
  10. Chicago—ALS Protein SOD1 Painted as Disease Template

Paper Citations

  1. . Feature Article: From the Cover: A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):20881-90. PubMed.
  2. . hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 2013 Mar;125(3):413-23. PubMed.
  3. . The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J Mol Neurosci. 2011 Nov;45(3):522-31. PubMed.
  4. . Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010 Dec 9;68(5):857-64. PubMed.
  5. . Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004 Apr;36(4):377-81. PubMed.
  6. . ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010 Aug 18;29(16):2841-57. PubMed.
  7. . Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies. J Neurosci. 2012 Jun 13;32(24):8270-83. PubMed.
  8. . TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem. 2005 Nov 11;280(45):37572-84. PubMed.
  9. . Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012 May 11;149(4):753-67. PubMed.
  10. . Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener. 2012;7:56. PubMed.
  11. . The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012 Jun 26;1462:61-80. PubMed.
  12. . ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009 Sep 8;73(10):805-11. PubMed.
  13. . Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012 Nov 16;338(6109):949-53. PubMed.
  14. . Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013 Mar 28;495(7442):467-73. PubMed.

Further Reading


  1. . Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: From structural insights to post-transcriptional regulatory roles. Mol Cell Neurosci. 2012 Dec 14; PubMed.
  2. . Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012 Nov 16;338(6109):949-53. PubMed.
  3. . Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice. EMBO Mol Med. 2012 Aug;4(8):730-42. PubMed.
  4. . Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration. Rejuvenation Res. 2011 Jun;14(3):275-81. PubMed.
  5. . TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum Mol Genet. 2011 Apr 1;20(7):1400-10. PubMed.
  6. . Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res. 2010 Feb 5;9(2):1104-20. PubMed.
  7. . Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013 Mar 28;495(7442):467-73. PubMed.

Primary Papers

  1. . Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013 Mar 28;495(7442):467-73. PubMed.